Friday, May 10, 3:00pm - 4:00pm (EDT)
Time zone
am/pm
24h
Suggestions
Your search did not return any results.
In 2007, Dr. David Schlaepfer joined the UC San Diego Health Moores Cancer Center, Division of Gynecologic Oncology as a Professor in the Department of Obstetrics, Gynecology, and Reproductive Sciences. The FAK gene (PTK2) is localized to a genetic locus (8q24) linked to ovarian cancer and elevated FAK expression occurs as a function of tumor progression. Using multiple cutting-edge research tools and newly-derived ovarian syngeneic mouse tumor models, Schlaepfer lab studies have provided insights into tumor chemotherapy resistance and new checkpoint immunotherapy combinations with small molecule FAK inhibitors that are being tested in human clinical trials.
You're going to "STT Seminar | Focal Adhesion Kinase (FAK) Signaling: Uncovering Tumor Vulnerabilities and Expanding Clinical Opportunities".
We've sent a confirmation email to your email address. Be sure to check your junk folder in case you haven't received the confirmation.
In 2007, Dr. David Schlaepfer joined the UC San Diego Health Moores Cancer Center, Division of Gynecologic Oncology as a Professor in the Department of Obstetrics, Gynecology, and Reproductive Sciences. The FAK gene (PTK2) is localized to a genetic locus (8q24) linked to ovarian cancer and elevated FAK expression occurs as a function of tumor progression. Using multiple cutting-edge research tools and newly-derived ovarian syngeneic mouse tumor models, Schlaepfer lab studies have provided insights into tumor chemotherapy resistance and new checkpoint immunotherapy combinations with small molecule FAK inhibitors that are being tested in human clinical trials.
Comer Commons and Zoom: https://uchealth.zoom.us/j/86111473843 false MM/DD/YYYY 60 OPAQUE aRHTJAtebzuytgVCsmlE218689You're interested in "STT Seminar | Focal Adhesion Kinase (FAK) Signaling: Uncovering Tumor Vulnerabilities and Expanding Clinical Opportunities".
We've sent a confirmation email to your email address. Be sure to check your junk folder in case you haven't received the confirmation.
In 2007, Dr. David Schlaepfer joined the UC San Diego Health Moores Cancer Center, Division of Gynecologic Oncology as a Professor in the Department of Obstetrics, Gynecology, and Reproductive Sciences. The FAK gene (PTK2) is localized to a genetic locus (8q24) linked to ovarian cancer and elevated FAK expression occurs as a function of tumor progression. Using multiple cutting-edge research tools and newly-derived ovarian syngeneic mouse tumor models, Schlaepfer lab studies have provided insights into tumor chemotherapy resistance and new checkpoint immunotherapy combinations with small molecule FAK inhibitors that are being tested in human clinical trials.
Comer Commons and Zoom: https://uchealth.zoom.us/j/86111473843 false MM/DD/YYYY 60 OPAQUE aRHTJAtebzuytgVCsmlE218689Thank you!
Your changes have been saved. Thanks for keeping us updated.
Comer Commons and Zoom: https://uchealth.zoom.us/j/86111473843
David Schlaepfer, PhD